Compare T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Inverse MSTR Daily Target ETF vs Tempus AI — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $11.35, while Tempus AI trades at $54.49 (market cap $10.05B). The key difference: T-Rex 2X Inverse MSTR Daily Target ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| MSTZ | TEM | |
|---|---|---|
Sector | Leveraged / Inverse | Broad Market / Factor |
52-Week High | $27.92 | $103.25 |
52-Week Low | $3.88 | $41.55 |
Market Cap | — | $10.05B |
Enterprise Value | — | $10.68B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSTZ stock trades at $11.40, showing a 5.36% daily gain amid bearish technical signals. The stock faces selling pressure with moving averages indicating a downtrend, while oscillators remain neutral. Financial ratios including P/E, P/S, and P/B are unavailable in current data. Recent ETF performance news indirectly references momentum names but lacks direct MSTZ coverage.
The outlook remains cautious with technical indicators favoring bearish momentum. Investment opportunity hinges on fundamental improvements currently obscured by missing financial data. Key risks include continued technical weakness and lack of clear fundamental catalysts. Investors should await earnings clarity for directional conviction.
Tempus AI (TEM) trades at $54.61, down 0.82% with a bullish technical outlook despite negative profitability. The company shows strong revenue growth with 2026 revenue guidance raised to $1.4B, though net losses persist. Recent Q2 earnings beat expectations with a narrower loss of $0.04 per share versus $0.14 expected. Technical indicators show bullish momentum with support at $54 and resistance at $57.
Investment outlook balances growth potential against profitability challenges. Analyst consensus is strongly bullish with 61.5% buy ratings and $61.57 price target, representing 13% upside. Key risks include sustained negative cash flow from operations and high valuation multiples amid ongoing losses. The Personalis acquisition expands MRD testing capabilities but integration execution remains a watchpoint.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
